http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2c340935473f8a4275d2737d454a9ac
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Naoyuki Taniguchi Taniguchi |
| name | Naoyuki Taniguchi |
| given-name | Naoyuki |
| organization-name | Osaka University Medical School Osaka Japan From the Department of Geriatric Medicine (E.N., N.K., H.O., H.M., Y.W., T.K.), Graduate School of Medicine, Kyoto University, Kyoto, Japan, and the Department of Biochemistry (S.H., N.T.), Osaka University Medical School, Osaka, Japan. Disease Glycomics Team; Systems Glycobiology Research Group; Global Research Cluster; RIKEN; Saitama 351-0198 Disease Glycomics Team; Systems Glycobiology Research Group; RIKEN-Max Planck Joint Research Center for Systems Chemical Biology; RIKEN Global Research Cluster; RIKEN Departments of Biochemistry, Internal Medicine and Molecular Science, and Glycotherapeutics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan; Department of Cell Biology, Saga University School of Medicine, Saga 809-8501, Japan; Department of Biochemistry, Hyogo College of Medicine, Hyogo 663-8501, Japan; Fukui Safety Institute, Ono Pharmaceutical Co., Fukui 913-8538, Japan; Department of Biochemistry, Yamagata University School of Medicine, Yamagata 990-9585, Japan; Department of... Disease Glycomics Team, Systems Glycobiology Research Group, RIKENMax Planck Joint Research Center, Global Research Cluster, RIKEN, Hirosawa, Wako, Saitama, Japan seika@biochem.med.osaka-u.ac.jp From the First Department of Medicine (N.Y., S.H., T.K., M.H.), the Department of Pathophysiology (T.K.), and the Department of Biochemistry (N.T.), Osaka University Medical School, Suita, Osaka, Japan. Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, Mitaka 181-8611, Japan; Department of Biochemistry, Osaka University Medical School, Suita 565-0871, Japan; Department of Traumatology and Critical Care Medicine, National Defense Medical College, Tokorozawa 359-8513, Japan; Watanabe Clinic, Shizuoka 422-8067, Japan; Division of Immunobiology, Research Section of Pathophysiology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815,... ¶Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center, RIKEN Global Research Cluster, Wako, Saitama, 351-0198, Japan From the Department of Biochemistry (Y.S.P., Y.M., R.T., M.T., N.T.) and the Department of Disease Glycomics, Research Institute for Microbial Diseases (N.T.), Osaka University, Japan; the Department of Microbiology (Y.S.P.), College of Medicine, Kyung Hee University, Seoul, Korea; and the Urological Diseases Research Center (J.K., M.R.F.), Children’s Hospital Boston, Harvard Medical School, Boston, Mass. Department of Glyco-Oncology and Medical Biochemistry, Research Institute, Osaka International Cancer Institute From the Second Department of Internal Medicine (K.F., S.K., Y.I., Y. Matsuda, T.I., S.T., Y. Matsuzawa) and the Department of Biochemistry (S.H., N.T.), Osaka University Medical School, Japan. Department of BiochemistryOsaka University Medical School Suita Osaka 565-0871 Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka, Japan Systems Glycobiology Research Group Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka, Japan. Disease Glycomics Team; Global Research Cluster; RIKEN-Max Planck Joint Research Center for Systems Chemical Biology; Wako-shi; Japan 1Department of Biochemistry, Osaka University Graduate School of Medicine, 2-2 Yamadaoka;; 2Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, Center for Advanced Science & Innovation, 2-1 Yamadaoka, Suita, Osaka, Japan; and Department of Molecular Biochemistry and Clinical Investigation, Osaka University Graduate School of Medicine, Osaka, Japan, Glycomics Research Laboratory Moritex Corporation, Yokohama, Japan, Reseach Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology, Ibaraki, Japan, Department of Structural Biology and Biomolecular Engineering, Nagoya City University Graduate School of Pharmaceutical Sciences, Nagoya, Japan, and Department of Disease Glycomics, Research... aDepartment of Biochemistry, Osaka University Medical School, Suita, Osaka 565-0871, Japan Department of BiochemistrySuitaOsakaJapan; Department of Disease GlycomicsResearch Institute for Microbial DiseasesOsaka UniversitySuitaOsakaJapan Department of Glyco‐Oncology Osaka International Cancer Institute Japan Disease Glycomics Team RIKEN‐Max Planck Joint Research Center, Global Research Cluster, RIKEN Wako Saitama Japan System Glycobiology Research Group RIKEN Wako Saitama Japan Disease Glycomics Team, Systems Glycobiology Research Group, Chemical Biology Department, RIKEN-Max Planck Joint Research Center, RIKEN Global Research Cluster, Wako, Saitama 351-0198, Japan Systems Glycobiology Research Group, RIKEN−Max Planck Joint Research Center, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan 2Department of Biochemistry, Osaka University Medical School/Graduate School of Medicine, Suita, Japan; 4Department of Biochemistry, Osaka University Medical School, Osaka, Japan; and From the Department of Internal Medicine and Molecular Science Graduate School of Medicine (M.N., J.M., S.Y., A.N., N.O., R.T., K.Y., S.K., Y.M.), Osaka University, and the Department of Biological Chemistry and Molecular Pharmacology (S.H., N.T.), Osaka University Medical School, Osaka, Japan. Disease Glycomics Team, Systems Glycobiology Research Group, RIKEN‐Max Planck Joint Research Center for Systems Chemical Biology, Global Research Cluster RIKEN Wako Japan From the Second Department of Internal Medicine and Department of Biochemistry (S.H., N.T.), Osaka University Medical School, Osaka, Japan. Department of Environmental Medicine, Graduate School of Environmental Science, Hokkaido University Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center for Systems Chemical Biology, Global Research Cluster, RIKEN, Wako, Saitama, Japan. Electronic address: dglycotani@riken.jp. Department of Disease Glycomics, Institute for Microbial Diseases, Osaka University, 2-1 Suita, Osaka 565-0871, Japan. tani52@wd5.so-net.ne.jp Department of Glyco‐Oncology and Medical Biochemistry Osaka International Cancer Institute Osaka Japan ‖Systems Glycobiology Research Group, Advanced Science Institute, RIKEN, Saitama 351-0198, Japan Department of Biochemistry, Osaka University Medical School, Osaka, Japan Department of Biochemistry, Osaka University Medical School, Osaka 565-0871, Japan. Department of Biochemistry, Osaka University Medical School Osaka, Japan Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center for Systems Chemical Biology, Global Research Cluster, Hirosawa, Wako, Saitama, Japan; Disease Glycomics Team, Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan; Systems Glycobiology Research Group RIKEN‐Max Plank Joint Research Center for Systems Chemical Biology Global Research Cluster RIKEN Wako Saitama Japan Department of Biochemistry, Osaka University, Graduate School of Medicine,Osaka 565-0871, Japan. Systems Glycobiology Research Group; RIKEN-Max Planck Joint Research Center for Systems Chemical Biology; RIKEN Global Research Cluster; RIKEN; Saitama 351-0198, Japan the Second Department of Internal Medicine (T.I., S.K., J.M., Y.I., S.T., K.F., K.I., K.Y., Y.M.) and Department of Biochemistry (N.T., S.H.), Osaka (Japan) University Medical School. Osaka International Cancer Institute Research Center, , 3-1-69 Otemae, Chuoku, Osaka 541-1181 Japan Endowed Chair Professor, Osaka University, Program Director, RIKEN Advanced Science Institute (Japan) Department of BiochemistryOsaka University Medical School2–2 YamadaokaSuitaOsaka565–0871Japan 21st Century Centers of Excellence Program, Osaka University Medical School, Suita, Osaka 565-0871, Japan;; Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan Disease Glycomics Team, Systems Glycobiology Research Group, Global Research Cluster RIKEN Saitama Japan Division of Regulatory Glycobiology, Tohoku Pharmaceutical University, Sendai Miyagi 981-8558, Japan, Department of Disease Glycomcis, Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan, and Systems Glycobiology Group, Disease Glycomics Team, RIKEN, Wako 351-0198, Japan Systems Glycobiology Research Group; Global Research Cluster; Wako Saitama Japan Disease Glycomics Team Global Research Center RIKEN‐Max Planck Joint Research Center for System Chemical Biology RIKEN, 2‐1 Hirosawa Wako‐shi Saitama 351‐0198 Japan Disease Glycomics Team, Systems Glycobiology Research Group, RIKEN–Max Planck Joint Research Centre for Systems Chemical Biology, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan Biochemistry, Osaka Police Hospital, Osaka, Japan Department of Glyco-Oncology and Medical Biochemistry, Osaka International Cancer Institute, Osaka, Japan. glycotani@mc.pref.osaka.jp. Disease Glycomics Team, RIKEN, Tokyo 351-0198, Japan; From the First Department of Medicine (N.Y., S.H., K.O., T.K., M.H.), Department of Pathophysiology (T.K.), and Department of Biochemistry (N.T.), Osaka University Medical School, and the Cardiovascular Division, Osaka Rosai Hospital (S.H.), Osaka, Japan. Disease Glycomics Team and; RIKEN-Max Planck Institute Joint Research Center, Saitama, Japan; and Department of Pediatric Surgery Fukuoka Children’s Hospital Fukuoka Japan Systems Glycobiology Group, RIKEN, Japan Disease Glycomics Team RIKEN‐Max Planck Joint Research Center Global Research Cluster RIKEN Wako Japan Department of Biochemistry, Osaka University Medical School, 2-2 Yamadaoka, and Department of Pathology, Osaka University Dental School, 1-8 Yamadaoka, Suita, Osaka 565, Japan; and Department of Developmental Genetics, Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, 4-24-1 Kuhonji, Kumamoto 862, Japan Department of Biochemistry, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan Department of Disease Glycomics, Institute for Microbial Diseases, Osaka University, Suita, Osaka 567-0871, Japan. tani52@wd5.so-net.ne.jp International Center for Biotechnology, Research Institute for Microbial Diseases, Department of Disease Glycomics, Department of Molecular Biochemistry and Clinical Investigation, Graduate School of Medicine, and Graduate School of Frontier Bioscience, Osaka University, Suita, Osaka 565-0871, Japan the Second Department of Internal Medicine and the Department of Biochemistry (N.T., S.H.), Osaka (Japan) University Medical School. Disease Glycomics Team; Global Research Cluster; RIKEN-Max Planck Joint Research Center for Systems Chemical Biology; RIKEN; Saitama Department of Glycotherapeutics, Department of Functional Diagnostic Science, Division of Health Science, Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Osaka 565-0871, Japan and Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan Disease Glycomics Team, RIKEN-Max Planck Joint Research Center, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan Systems Glycobiology Research Group, RIKEN-Max Planck Joint Research Center, Global Research Cluster, RIKEN, Wako 351-0198, Japan Disease Glycomics Team, Systems Glycobiology Research Group, Global Research Cluster, RIKEN, Wako, Saitama 351-0198, Japan Biochemistry Laboratory Cancer Research Institute Systems Glycobiology Research Group, RIKEN, Advanced Science Institute, Wako, Saitama 351-0198, Japan Department of Biochemistry, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan; Research Institute, Osaka Medical Center for Maternal and Child Health, 840 Murodo-cho, Izumi, Osaka 594-1101, Japan; Department of Pathology and Laboratory Medicine and Neuroscience Center, University of North Carolina, Chapel Hill, NC 27599; Department of Physiology, Hokkaido University School of Medicine, Sapporo 060-8638, Japan; Department of Physical Therapy, College of Medical Technology,... Systems Glycobiology Research Group, Advanced Science Institute, RIKEN, Wako, Saitama 351-0198, Japan; and 21st COE (Center of Excellence) Program, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan; Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, Japan |
Incoming Links
Total number of triples: 667.